Pharma Reviews: Cipla announces Q2 FY22 results - Express Pharma

▫One India: Overall business grew by 16% YoY on high FY21 base led by ... Cipla's TRx market share stood at 18.2% of the generic market and 14.6% ...
Read more: Cipla announces Q2 FY22 results - Express Pharma